Long-Term Clinical Outcomes of Medroxyprogesterone Acetate as Gender-Affirming Therapy
Medroxyprogesterone acetate treatment significantly reduces testosterone with few side effects and no change in estradiol levels.
General Endocrinology
Growth Hormone Treatment Does Not Affect Health-Related QoL in Turner Syndrome
Growth hormone treatment in childhood did not significantly affect health-related quality of life in adult women with Turner syndrome.
NSAID, Metoclopramide Use Associated With Insulin Resistance in Women With Migraine
The use of metoclopramide and non-steroidal anti-inflammatory drugs during migraine attacks may be associated with insulin resistance in women with migraine.
Adverse Drug Reactions May Differ According to Sex
The risk for adverse drug reactions (ADRs) may be higher for women, even when accounting for gender differences in drug use.
Multiple Measurements of AMH Levels Do Not Improve Prediction of Menopause
Multiple measurements of anti-müllerian hormone over time do not improve the prediction of age at menopause.
How Does Chronic Exposure to Cortisol Affect Turner Syndrome Comorbidities?
Chronically high cortisol levels in Turner syndrome are linked to short stature, elevated total cholesterol levels, and possibly a greater risk for cardiovascular disease.
Dos and Don’ts: Caring for Patients With Rare Diseases
Physicians must recognize that patients with rare diseases are often the experts on their conditions.
Endoscopic Ultrasound-Guided RFA Is a Safe, Feasible Treatment Option for Pancreatic Neuroendocrine Tumors
In select patients with pancreatic neuroendocrine tumors, endoscopic ultrasound-guided radiofrequency ablation is a viable treatment modality that is relatively safe and effective.
Case Study: Headaches During Immunotherapy Treatment for Malignant Melanoma
A 56-year-old man with a history of melanoma and a recent diagnosis of hypothyroidism was referred to the emergency department after complaints of significant fatigue and headache.
Endocrine Society Supports European Parliament’s Call for Endocrine-Disrupting Chemical Regulation
The Endocrine Society commended the new resolution from the European Parliament addressing regulation of endocrine-disrupting chemicals.
Next post in Practice Management
